ABVC BioPharma, Inc. Gain (Loss) on Investments
ABVC BioPharma, Inc. (ABVC) reported Gain (Loss) on Investments of -$24.77 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2026-08-12
- ABVC BioPharma, Inc. gain (loss) on investments for the quarter ending 2026-06-30 was -$24.77K.
- ABVC BioPharma, Inc. gain (loss) on investments for the quarter ending 2026-03-31 was -$31.42K.
- ABVC BioPharma, Inc. gain (loss) on investments for the quarter ending 2025-06-30 was -$44.92K.
- ABVC BioPharma, Inc. gain (loss) on investments for the quarter ending 2025-03-31 was -$50.88K.
- ABVC BioPharma, Inc. gain (loss) on investments for fiscal 2025 was -$192.76K.
- ABVC BioPharma, Inc. gain (loss) on investments for fiscal 2024 was -$339.17K.
- ABVC BioPharma, Inc. gain (loss) on investments for fiscal 2023 was -$221.89K.
- ABVC BioPharma, Inc. gain (loss) on investments for fiscal 2022 was -$7.45K.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 12 month | Gain (Loss) on Investments 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$24.77K 10-Q · filed 2026-08-12 | -$56.18K 10-Q · filed 2026-08-12 | |||
| 2026-03-31 | -$31.42K 10-Q · filed 2026-05-18 | ||||
| 2025-12-31 | -$192.76K 10-K · filed 2026-03-03 | ||||
| 2025-06-30 | -$44.92K 10-Q · filed 2026-08-12 | -$95.79K 10-Q · filed 2026-08-12 | -$288.02K derived: sum of 3 quarters · filed 2026-08-12 | -$355.91K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | -$50.88K 10-Q · filed 2026-05-18 | -$243.11K derived: sum of 2 quarters · filed 2026-05-18 | -$310.99K derived: sum of 3 quarters · filed 2026-05-18 | ||
| 2024-12-31 | -$192.23K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$260.11K derived: sum of 2 quarters · filed 2026-03-03 | -$339.17K 10-K · filed 2026-03-03 | ||
| 2024-09-30 | -$67.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$146.94K 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | -$79.06K 10-Q · filed 2025-08-13 | ||||
| 2023-12-31 | -$221.89K 10-K · filed 2025-04-15 | ||||
| 2022-12-31 | -$7.45K 10-K · filed 2024-03-13 | ||||
| 2020-12-31 | -$2.32K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$1.65K derived: sum of 2 quarters · filed 2021-03-16 | -$40.59K derived: sum of 3 quarters · filed 2021-03-16 | -$40.59K 10-K · filed 2021-03-16 | |
| 2020-09-30 | $665.00 10-Q · filed 2020-11-17 | -$38.27K derived: sum of 2 quarters · filed 2020-11-17 | -$38.27K 10-Q · filed 2020-11-17 | ||
| 2020-06-30 | -$38.94K 10-Q · filed 2020-08-14 | -$38.94K 10-Q · filed 2020-08-14 | |||
| 2020-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2021-03-16 | ||||
| 2019-03-31 | -$66.20K 10-Q · filed 2019-05-28 | $221.86K derived: sum of 2 quarters · filed 2024-08-14 | $20.27K derived: sum of 3 quarters · filed 2024-08-14 | -$65.66K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2018-12-31 | $288.06K derived: 10-Q 12 month − 10-Q 9 month · filed 2024-08-14 | $86.47K derived: sum of 2 quarters · filed 2024-08-14 | $549.00 derived: sum of 3 quarters · filed 2024-08-14 | $549.00 10-Q · filed 2024-08-14 | -$549.00 10-K · filed 2019-04-15 |
| 2018-09-30 | -$201.59K 10-Q · filed 2019-11-18 | -$287.51K derived: sum of 2 quarters · filed 2019-11-18 | -$287.51K 10-Q · filed 2019-11-18 | ||
| 2018-06-30 | -$85.92K 10-Q · filed 2019-08-09 | -$85.92K 10-Q · filed 2019-08-09 | |||
| 2018-03-31 | -$38.57K 10-Q · filed 2019-05-28 |